<!DOCTYPE html SYSTEM "about:legacy-compat">
<html lang="en-US" class="no-js">
  <head>
    <meta charset="utf-8"/>
    <title>Chapter 8H. Specialty Drug Copayment Limitation. | D.C. Law Library</title>
    <link rel="shortcut icon" href="/us/dc/_document/v2/images/favicons/favicon.ico"/>
    <!--Meta-->
    <meta http-equiv="X-UA-Compatible" content="IE=EDGE"/>
    <meta name="viewport" content="width=device-width, initial-scale=1"/>
    <meta name="format-detection" content="telephone=no"/>
    <meta name="HandheldFriendly" content="true"/>
    <meta itemprop="full-html" content="/us/dc/council/code/titles/48/chapters/8H/index.full.html"/>
    <meta itemprop="toc-json" content="/us/dc/council/code/titles/48/chapters/8H/index.json"/>
    <meta itemprop="parent-doc-url" content="/us/dc/council/code"/>
    <meta itemprop="order" content="|48|8H|"/>
    <meta itemprop="doc-type" content="container"/>
    <meta itemprop="ref-doc" content="D.C. Code"/>
    <meta itemprop="ref-path" content="48|8H"/>
    <!--OpenGraph-->
    <meta property="og:url" content="https://code.dccouncil.us/us/dc/council/code/titles/48/chapters/8H"/>
    <meta property="og:type" content="article"/>
    <meta property="og:title" content="Chapter 8H. Specialty Drug Copayment Limitation. | D.C. Law Library"/>
    <meta property="og:image" content="https://code.dccouncil.us/us/dc/_document/v2/images/og/og_image.png"/>
    <!--Progressive Web App-->
    <link rel="manifest" href="/manifest.json"/>
    <meta name="msapplication-config" content="/browserconfig.xml"/>
    <meta name="apple-mobile-web-app-capable" content="yes"/>
    <meta name="apple-mobile-web-app-status-bar-style" content="#000000"/>
    <meta name="apple-mobile-web-app-title" content="D.C. Law Library"/>
    <meta name="theme-color" content="#000000"/>
    <meta name="msapplication-navbutton-color" content="#000000"/>
    <meta name="apple-mobile-web-app-capable" content="yes"/>
    <meta name="mobile-web-app-capable" content="yes"/>
    <!--PWA icons-->
    <link rel="apple-touch-icon" sizes="180x180" href="/us/dc/_document/v2/images/favicons/apple-touch-icon.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="60x60" href="/us/dc/_document/v2/images/favicons/apple-touch-icon-60x60-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="76x76" href="/us/dc/_document/v2/images/favicons/apple-touch-icon-76x76-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="152x152" href="/us/dc/_document/v2/images/favicons/apple-touch-icon-152x152-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="180x180" href="/us/dc/_document/v2/images/favicons/apple-touch-icon-180x180-precomposed.png"/>
    <link rel="mask-icon" href="/us/dc/_document/v2/images/favicons/safari-pinned-tab.svg" color="#000000"/>
    <link rel="icon" type="image/png" sizes="16x16" href="/us/dc/_document/v2/images/favicons/favicon-16x16.png"/>
    <link rel="icon" type="image/png" sizes="32x32" href="/us/dc/_document/v2/images/favicons/favicon-32x32.png"/>
    <link rel="icon" type="image/png" sizes="48x48" href="/us/dc/_document/v2/images/favicons/favicon-48x48.png"/>
    <!--Fonts-->
    <link href="/us/dc/_document/v2/biticons/biticons.css" type="text/css" rel="stylesheet"/>
    <link href="/us/dc/_document/v2/fonts/droid-serif/droid-serif.css" type="text/css" rel="stylesheet"/>
    <link href="/us/dc/_document/v2/fonts/open-sans/open-sans.css" type="text/css" rel="stylesheet"/>
    <!--Document CSS-->
    <link href="/us/dc/_document/v2/styles/responsive.min.css" type="text/css" rel="stylesheet" media="screen"/>
    <link href="/us/dc/_document/v2/styles/main.min.css" type="text/css" rel="stylesheet" media="screen"/>
    <link href="/us/dc/_document/v2/styles/print.min.css" type="text/css" rel="stylesheet" media="print"/>
    <link href="/_reader/styles/main.min.css" type="text/css" rel="stylesheet"/>
    <script src="/_reader/js/main.js"> </script>
    <!--Links to resources that need to be prefetched-->
    <link rel="prefetch" href="/us/dc/council/code/titles/48/chapters/8H/index.full.html" as="fetch"/>
  </head>
  <body>
    <div role="region" id="announcer" aria-live="polite" class="sr-only" aria-atomic="true" aria-label="Live messages">
      <p id="message"> </p>
    </div>
    <nav class="visually-hidden">
      <a href="#area__content" class="skip-link">Skip to main content</a>
    </nav>
    <div id="grid" class="ns__document__us-dc">
      <header id="section__header" class="ns__document__us-dc">
        <div id="section__header__inner" class="ns__document__us-dc">
          <div id="area__logo" class="ns__document__us-dc">
            <a href="/" class="logo" aria-label="Logo - Return to home page">
              <img src="/us/dc/_document/v2/images/logo/dc-seal-outline.png" srcset="/us/dc/_document/v2/images/logo/dc-seal-outline.png 1x, /us/dc/_document/v2/images/logo/dc-seal-outline@2x.png 2x" alt="Council of the District of Columbia logo"/>
            </a>
          </div>
          <div id="area__main_title" class="ns__document__us-dc">
            <img src="/us/dc/_document/v2/images/logo/dccouncil_typemark.svg" srcset="" alt="D.C. Law Library"/>
          </div>
        </div>
      </header>
      <div id="section__content" class="ns__document__us-dc">
        <div id="section__content__inner" class="ns__document__us-dc">
          <section id="area__breadcrumbs" class="ns__document__us-dc" role="region" aria-label="Breadcrumbs">
            <input type="checkbox" id="menu-trigger" class="menu-trigger" aria-label="Mobile menu toggler"/>
            <label for="menu-trigger">
              <span class="visually-hidden">Toggle mobile menu</span>
            </label>
            <nav role="navigation" aria-label="Breadcrumb navigation">
              <div class="h__ui">Navigation</div>
              <ul class="ancestors">
                <li data-search-path="library" data-search-heading="All Documents" class="no-indent">
                  <a href="/" title="D.C. Law Library">D.C. Law Library</a>
                </li>
                <li data-search-path="library|D.C. Code" data-search-heading="" data-search-default="true" class="li__book-open">
                  <a href="/us/dc/council/code" title="Code of the District of Columbia">Code of the District of Columbia</a>
                </li>
                <li data-search-path="library|D.C. Code|48" data-search-heading="">
                  <a href="/us/dc/council/code/titles/48" title="Title 48. Foods and Drugs.">Title 48. Foods and Drugs.</a>
                </li>
                <li data-search-path="library|D.C. Code|48|8H" data-search-heading="">
                  <span title="Chapter 8H. Specialty Drug Copayment Limitation.">Chapter 8H. Specialty Drug Copayment Limitation.</span>
                </li>
              </ul>
            </nav>
          </section>
          <main id="area__content" class="ns__document__us-dc">
            <div class="h__document-title">Code of the District of Columbia</div>
            <article class="content" role="document" data-ref-path="48|8H">
              <div class="tuf-authenticate">
                <h1 class="h__toc" id="/us/dc/council/code/titles/48/chapters/8H">Chapter 8H. Specialty Drug Copayment Limitation.</h1>
                <h2 id="/us/dc/council/code/sections/48-855.01" data-order="|48|8H|48-855.01|" data-ref-path="§48-855.01" class="h__section">§ 48–855.01. Definitions.</h2>
                <p>For the purposes of <a class="internal-link no-wrap" href="/us/dc/council/code/titles/48/chapters/8H" title="Chapter 8H. Specialty Drug Copayment Limitation.">this chapter</a>, the term:</p>
                <p class="text-indent-1"><span class="level-num" id="/us/dc/council/code/sections/48-855.01#(1)">(1)</span> "Class of drugs" means a group of medications having similar actions designed to treat a particular disease process.</p>
                <p class="text-indent-1"><span class="level-num" id="/us/dc/council/code/sections/48-855.01#(2)">(2)</span> "Coinsurance" means a cost-sharing amount set as a percentage of the total cost of a drug.</p>
                <p class="text-indent-1"><span class="level-num" id="/us/dc/council/code/sections/48-855.01#(3)">(3)</span> "Copayment" means a cost-sharing amount set as a dollar value.</p>
                <p class="text-indent-1"><span class="level-num" id="/us/dc/council/code/sections/48-855.01#(3A)">(3A)</span> "Diabetes device" means a legend device or non-legend device used to cure, diagnose, mitigate, prevent or treat diabetes or low blood sugar.  The term includes a blood glucose test strip, glucometer, continuous glucometer, lancet, lancing device, or insulin syringe.</p>
                <p class="text-indent-1"><span class="level-num" id="/us/dc/council/code/sections/48-855.01#(3B)">(3B)</span> "Diabetic ketoacidosis device" means a device that is a legend or non-legend device and used to screen for or prevent diabetic ketoacidosis. The term includes diabetic ketoacidosis devices prescribed and dispensed once during a policy year.</p>
                <p class="text-indent-1"><span class="level-num" id="/us/dc/council/code/sections/48-855.01#(3C)">(3C)</span> "Generic drug" means a chemically equivalent copy of a brand-name drug with an expired patent.</p>
                <p class="text-indent-1"><span class="level-num" id="/us/dc/council/code/sections/48-855.01#(4)">(4)</span><span class="level-num" id="/us/dc/council/code/sections/48-855.01#(4)(A)">(A)</span> "Health benefit plan" means a policy, contract, certificate, or agreement offered or issued by a health carrier to provide, deliver, arrange for, pay for, or reimburse any of the costs of health care services.</p>
                <p class="text-indent-2"><span class="level-num" id="/us/dc/council/code/sections/48-855.01#(4)(B)">(B)</span> The term "health benefit plan" does not include:</p>
                <p class="text-indent-3"><span class="level-num" id="/us/dc/council/code/sections/48-855.01#(4)(B)(i)">(i)</span> Coverage only for accident or disability income insurance, or any combination thereof;</p>
                <p class="text-indent-3"><span class="level-num" id="/us/dc/council/code/sections/48-855.01#(4)(B)(ii)">(ii)</span> Liability insurance, including general liability insurance and automobile liability insurance;</p>
                <p class="text-indent-3"><span class="level-num" id="/us/dc/council/code/sections/48-855.01#(4)(B)(iii)">(iii)</span> Coverage issued as a supplement to liability insurance;</p>
                <p class="text-indent-3"><span class="level-num" id="/us/dc/council/code/sections/48-855.01#(4)(B)(iv)">(iv)</span> Workers' compensation or similar insurance;</p>
                <p class="text-indent-3"><span class="level-num" id="/us/dc/council/code/sections/48-855.01#(4)(B)(v)">(v)</span> Automobile medical payment insurance;</p>
                <p class="text-indent-3"><span class="level-num" id="/us/dc/council/code/sections/48-855.01#(4)(B)(vi)">(vi)</span> Credit-only insurance;</p>
                <p class="text-indent-3"><span class="level-num" id="/us/dc/council/code/sections/48-855.01#(4)(B)(vii)">(vii)</span> Coverage for on-site medical clinics; or</p>
                <p class="text-indent-3"><span class="level-num" id="/us/dc/council/code/sections/48-855.01#(4)(B)(viii)">(viii)</span> Other similar insurance coverage specified in federal regulations issued pursuant to the Health Insurance Portability and Accountability Act of 1996, approved August 21, 1996 (110 Stat. 1936; scattered sections of the United States Code) ("HIPAA"), under which benefits for health care services are secondary or incidental to other insurance benefits.</p>
                <p class="text-indent-2"><span class="level-num" id="/us/dc/council/code/sections/48-855.01#(4)(C)">(C)</span> The term "health benefit plan" does not include the following benefits if they are provided under a separate policy, certificate of insurance, or contract of insurance, or are otherwise not an integral part of the plan:</p>
                <p class="text-indent-3"><span class="level-num" id="/us/dc/council/code/sections/48-855.01#(4)(C)(i)">(i)</span> Limited scope dental or vision benefits;</p>
                <p class="text-indent-3"><span class="level-num" id="/us/dc/council/code/sections/48-855.01#(4)(C)(ii)">(ii)</span> Benefits for long-term care, nursing-home care, home-health care, community-based care, or any combination thereof; or</p>
                <p class="text-indent-3"><span class="level-num" id="/us/dc/council/code/sections/48-855.01#(4)(C)(iii)">(iii)</span> Other similar, limited benefits specified in federal regulations issued pursuant to HIPAA.</p>
                <p class="text-indent-2"><span class="level-num" id="/us/dc/council/code/sections/48-855.01#(4)(D)">(D)</span> The term "health benefit plan" does not include the following benefits if the benefits are provided under a separate policy, certificate of insurance, or contract of insurance, and there is no coordination between the provision of the benefits and any exclusion of benefits under any group health plan maintained by the same health insurer, and the benefits are paid with respect to an event without regard to whether benefits are provided with respect to such an event under any group health plan maintained by the same health insurer:</p>
                <p class="text-indent-3"><span class="level-num" id="/us/dc/council/code/sections/48-855.01#(4)(D)(i)">(i)</span> Coverage only for a specified disease or illness; or</p>
                <p class="text-indent-3"><span class="level-num" id="/us/dc/council/code/sections/48-855.01#(4)(D)(ii)">(ii)</span> Hospital indemnity or other fixed indemnity insurance.</p>
                <p class="text-indent-2"><span class="level-num" id="/us/dc/council/code/sections/48-855.01#(4)(E)">(E)</span> The term "health benefit plan" does not include the following if offered as a separate policy, certificate of insurance, or contract of insurance:</p>
                <p class="text-indent-3"><span class="level-num" id="/us/dc/council/code/sections/48-855.01#(4)(E)(i)">(i)</span> A Medicare supplemental policy as defined in section 1882(g)(1) of the Social Security Act, approved June 9, 1980 (94 Stat. 476; 42 U.S.C. § 1395ss(g)(1));</p>
                <p class="text-indent-3"><span class="level-num" id="/us/dc/council/code/sections/48-855.01#(4)(E)(ii)">(ii)</span> Coverage supplemental to the coverage provided under An Act To amend titles 10, 14, and 32, United States Code, to codify recent military law, and to improve the Code, approved September 2, 1958 (72 Stat. 1437; 10 U.S.C. § 1071 <em>et seq</em>.); or</p>
                <p class="text-indent-3"><span class="level-num" id="/us/dc/council/code/sections/48-855.01#(4)(E)(iii)">(iii)</span> Similar supplemental coverage provided under a group health plan.</p>
                <p class="text-indent-1"><span class="level-num" id="/us/dc/council/code/sections/48-855.01#(5)">(5)</span> "Health insurer" means any person that provides one or more health benefit plans or insurance in the District of Columbia, including an insurer, a hospital and medical services corporation, a fraternal benefit society, a health maintenance organization, a multiple employer welfare arrangement, or any other person providing a plan of health insurance subject to the authority of the Commissioner of the Department of Insurance, Securities and Banking.</p>
                <p class="text-indent-1"><span class="level-num" id="/us/dc/council/code/sections/48-855.01#(5A)">(5A)</span> "Interchangeable biological product" means a biological product that is licensed and determined by the Food and Drug Administration to meet the standards for interchangeability under 42 U.S.C. § 262(k)(4) or determined to be biosimilar to and interchangeable with a reference biological product as stated in the Lists of Licensed Biological Products with Reference Product Exclusivity and Biosimilarity or Interchangeability Evaluations, also known as the Purple Books.</p>
                <p class="text-indent-1"><span class="level-num" id="/us/dc/council/code/sections/48-855.01#(6)">(6)</span> "Member" means an individual who is enrolled in a health benefit plan.</p>
                <p class="text-indent-1"><span class="level-num" id="/us/dc/council/code/sections/48-855.01#(7)">(7)</span> "Member representative" means a:</p>
                <p class="text-indent-2"><span class="level-num" id="/us/dc/council/code/sections/48-855.01#(7)(A)">(A)</span> Person acting on behalf of a member with the member's consent;</p>
                <p class="text-indent-2"><span class="level-num" id="/us/dc/council/code/sections/48-855.01#(7)(B)">(B)</span> Person authorized by law to provide substituted consent for a member;</p>
                <p class="text-indent-2"><span class="level-num" id="/us/dc/council/code/sections/48-855.01#(7)(C)">(C)</span> Family member of the member;</p>
                <p class="text-indent-2"><span class="level-num" id="/us/dc/council/code/sections/48-855.01#(7)(D)">(D)</span> Member's treating health care professional when the member is unable to provide consent; or</p>
                <p class="text-indent-2"><span class="level-num" id="/us/dc/council/code/sections/48-855.01#(7)(E)">(E)</span> In the case of a request regarding an emergency or urgent medical condition, a health-care professional with knowledge of the member's medical condition.</p>
                <p class="text-indent-1"><span class="level-num" id="/us/dc/council/code/sections/48-855.01#(8)">(8)</span> "Non-preferred drug" means a specialty drug formulary classification for certain specialty drugs that are subject to limits on eligibility for coverage or to higher cost-sharing amounts than preferred specialty drugs.</p>
                <p class="text-indent-1"><span class="level-num" id="/us/dc/council/code/sections/48-855.01#(9)">(9)</span> "Preferred drug" means a specialty drug formulary classification for certain specialty drugs that are not subject to limits on eligibility for coverage or to higher cost-sharing amounts than a non-preferred drug.</p>
                <p class="text-indent-1"><span class="level-num" id="/us/dc/council/code/sections/48-855.01#(9A)">(9A)</span> "Prescription insulin drug" means a prescription drug that contains insulin and is used to control blood glucose levels to treat diabetes.</p>
                <p class="text-indent-1"><span class="level-num" id="/us/dc/council/code/sections/48-855.01#(10)">(10)</span> "Specialty drug" means a prescription drug that:</p>
                <p class="text-indent-2"><span class="level-num" id="/us/dc/council/code/sections/48-855.01#(10)(A)">(A)</span> Is prescribed for a person with:</p>
                <p class="text-indent-3"><span class="level-num" id="/us/dc/council/code/sections/48-855.01#(10)(A)(i)">(i)</span> A physical, behavioral, or developmental condition that may have no known cure, is progressive, or can be debilitating or fatal if left untreated or undertreated, such as multiple sclerosis, hepatitis C, or rheumatoid arthritis; or</p>
                <p class="text-indent-3"><span class="level-num" id="/us/dc/council/code/sections/48-855.01#(10)(A)(ii)">(ii)</span> A disease or condition that affects fewer than 200,000 persons in the United States or approximately one in 1,500 persons worldwide, such as cystic fibrosis, hemophilia, or multiple myeloma;</p>
                <p class="text-indent-2"><span class="level-num" id="/us/dc/council/code/sections/48-855.01#(10)(B)">(B)</span> Has a total monthly prescription cost of $600 or more; and</p>
                <p class="text-indent-2"><span class="level-num" id="/us/dc/council/code/sections/48-855.01#(10)(C)">(C)</span> Has one or more of the following characteristics:</p>
                <p class="text-indent-3"><span class="level-num" id="/us/dc/council/code/sections/48-855.01#(10)(C)(i)">(i)</span> Is an oral, injectable, or infusible drug product or a drug product that is delivered topically, through inhalation, implantation, or transmucosally;</p>
                <p class="text-indent-3"><span class="level-num" id="/us/dc/council/code/sections/48-855.01#(10)(C)(ii)">(ii)</span> Requires unique storage or shipment, such as refrigeration; or</p>
                <p class="text-indent-3"><span class="level-num" id="/us/dc/council/code/sections/48-855.01#(10)(C)(iii)">(iii)</span> Requires patient education and support beyond traditional dispensing activities.</p>
                <p class="text-indent-1"><span class="level-num" id="/us/dc/council/code/sections/48-855.01#(11)">(11)</span> "Specialty tier" means a tier of cost sharing designed for select specialty drugs that imposes a cost-sharing obligation that is based on a coinsurance or copayment and exceeds that amount for non-specialty drugs.</p>
                <p class="text-indent-1"><span class="level-num" id="/us/dc/council/code/sections/48-855.01#(12)">(12)</span> "Step therapy" means a protocol established by a health insurer that requires a prescription drug or sequence of prescription drugs to be used by an insured or an enrollee before a prescription drug ordered by a prescriber for the insured or the enrollee is covered.</p>
                <p class="text-indent-1"><span class="level-num" id="/us/dc/council/code/sections/48-855.01#(13)">(13)</span> "Tiered formulary" means a formulary that provides coverage for prescription drugs as part of a health benefit plan for which cost-sharing, deductibles, or coinsurance is determined by category or tier of prescription drugs, and that includes at least 2 different tiers.</p>
                <aside class="annotations" role="note">
                  <p>
      (<a href="/us/dc/council/laws/21-248#§2" title="§ 2. Definitions.">Apr. 7, 2017, D.C. Law 21-248, § 2, 64 DCR 1624</a>; <a href="/us/dc/council/laws/23-252#§2(a)" title="">Mar. 16, 2021, D.C. Law 23-252, § 2(a), 68 DCR 001151</a>; <a href="/us/dc/council/laws/25-26#§2(a)" title="">July 20, 2023, D.C. Law 25-26, § 2(a), 70 DCR 7912</a>.)
    </p>
                </aside>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/dc/council/code/sections/48-855.02" data-order="|48|8H|48-855.02|" data-ref-path="§48-855.02" class="h__section">§ 48–855.02. Specialty drug copayment or coinsurance limitation.</h2>
                <p class="text-indent-1"><span class="level-num" id="/us/dc/council/code/sections/48-855.02#(a)">(a)</span><span class="level-num" id="/us/dc/council/code/sections/48-855.02#(a)(1)">(1)</span> A health benefit plan that provides coverage for prescription drugs shall ensure that a required copayment or coinsurance applicable to a drug on a specialty tier does not exceed $150 per month for up to a 30-day supply of the specialty drug or $300 for a 90-day supply.</p>
                <p class="text-indent-2"><span class="level-num" id="/us/dc/council/code/sections/48-855.02#(a)(2)">(2)</span> On July 1 of each year, the limit on a required copayment or coinsurance applicable to a drug on a specialty tier provided in paragraph (1) of this subsection shall increase by a percentage equal to the percentage change from the preceding year in the medical care component of the March Consumer Price Index for All Urban Consumers, Washington-Arlington-Alexandria, DC-VA-MD-WV metropolitan area, as published by the Bureau of Labor Statistics of the United States Department of Labor.</p>
                <p class="text-indent-1"><span class="level-num" id="/us/dc/council/code/sections/48-855.02#(b)">(b)</span><span class="level-num" id="/us/dc/council/code/sections/48-855.02#(b)(1)">(1)</span> For a health benefit plan that provides coverage for prescription drugs and utilizes a tiered formulary, a member or member representative shall have the right to request that a non-preferred drug be covered under the cost sharing applicable for preferred drugs if the prescribing physician determines that the preferred drug for treatment of the same condition either would not be as effective for the individual or would have adverse effects for the individual, or both.</p>
                <p class="text-indent-2"><span class="level-num" id="/us/dc/council/code/sections/48-855.02#(b)(2)">(2)</span> The denial of a request made pursuant to paragraph (1) of this subsection shall be considered an adverse event and shall be subject to the health benefit plan's internal review process.</p>
                <p class="text-indent-1"><span class="level-num" id="/us/dc/council/code/sections/48-855.02#(c)">(c)</span> A health benefit plan that provides coverage for prescription drugs shall not place all drugs in a given class of drugs on a specialty tier.</p>
                <p class="text-indent-1"><span class="level-num" id="/us/dc/council/code/sections/48-855.02#(d)">(d)</span> Nothing in this section shall be construed to require a health benefit plan to:</p>
                <p class="text-indent-2"><span class="level-num" id="/us/dc/council/code/sections/48-855.02#(d)(1)">(1)</span> Provide coverage for any additional drugs not otherwise required by law;</p>
                <p class="text-indent-2"><span class="level-num" id="/us/dc/council/code/sections/48-855.02#(d)(2)">(2)</span> Implement specific utilization management techniques, such as prior authorization or step therapy; or</p>
                <p class="text-indent-2"><span class="level-num" id="/us/dc/council/code/sections/48-855.02#(d)(3)">(3)</span> Cease the use of tiered cost-sharing structures, including strategies used to incentivize use of preventive services, disease management, and low-cost treatment options.</p>
                <p class="text-indent-1"><span class="level-num" id="/us/dc/council/code/sections/48-855.02#(e)">(e)</span> Nothing in this section shall be construed to require a pharmacist to substitute a drug without the consent of the prescribing physician.</p>
                <p class="text-indent-1"><span class="level-num" id="/us/dc/council/code/sections/48-855.02#(f)">(f)</span> A health insurer shall not be precluded from requiring specialty drugs to be obtained through a designated pharmacy or other source of specialty drugs.</p>
                <aside class="annotations" role="note">
                  <p>
      (<a href="/us/dc/council/laws/21-248#§3" title="§ 3. Specialty drug copayment or coinsurance limitation.">Apr. 7, 2017, D.C. Law 21-248, § 3, 64 DCR 1624</a>; <a href="/us/dc/council/laws/23-252#§2(b)" title="">Mar. 16, 2021, D.C. Law 23-252, § 2(b), 68 DCR 001151</a>.)
    </p>
                </aside>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/dc/council/code/sections/48-855.02a" data-order="|48|8H|48-855.02a|" data-ref-path="§48-855.02a" class="h__section">§ 48–855.02a. Insulin copayment or coinsurance limitation.</h2>
                <p class="text-indent-1"><span class="level-num" id="/us/dc/council/code/sections/48-855.02a#(a)">(a)</span> A health insurer that provides coverage for prescription insulin drugs pursuant to the terms of a health benefits plan the insurer offers shall limit the total amount that an insured is required to pay for a 30-day supply of covered prescription insulin drugs at an amount not to exceed $30, regardless of the quantity or type of covered prescription insulin drug used to fill the insured's prescription.</p>
                <p class="text-indent-1"><span class="level-num" id="/us/dc/council/code/sections/48-855.02a#(b)">(b)</span> A health insurer that provides coverage for diabetes devices and diabetic ketoacidosis devices pursuant to the terms of a health benefits plan offered by the insurer, shall limit the total amount that an insured is required to pay for a 30-day supply of all medically necessary covered diabetes devices and diabetic ketoacidosis devices that are in accordance with the insured's diabetes treatment plan at an amount not to exceed $100.</p>
                <p class="text-indent-1"><span class="level-num" id="/us/dc/council/code/sections/48-855.02a#(c)">(c)</span> Pursuant to subsections (a) and (b) of this section, prescription insulin drugs, diabetes devices, and diabetic ketoacidosis devices shall be covered without being subject to a deductible and any cost sharing paid by an insured shall be applied toward the insured's deductible and out of pocket maximum obligations.</p>
                <p class="text-indent-1"><span class="level-num" id="/us/dc/council/code/sections/48-855.02a#(d)">(d)</span> Nothing in this section prevents an insurer from reducing an insured's copayment or coinsurance by an amount greater than the amount specified in subsections (a) and (b) of this section.</p>
                <p class="text-indent-1"><span class="level-num" id="/us/dc/council/code/sections/48-855.02a#(e)">(e)</span> On July 1 of each year, the limit on a required copayment or coinsurance an insured is required to pay under subsections (a) and (b) of this section shall increase by a percentage equal to the percentage change from the preceding year in the medical care component of the Consumer Price Index for All Urban Consumers, Washington-Arlington-Alexandria, DC-VA-MD-WV metropolitan area, as published by the Bureau of Labor Statistics of the United States Department of Labor.</p>
                <p class="text-indent-1"><span class="level-num" id="/us/dc/council/code/sections/48-855.02a#(f)">(f)</span> This section shall apply as of January 1, 2022.</p>
                <aside class="annotations" role="note">
                  <p>
      (<a href="/us/dc/council/laws/21-248" title="D.C. Law 21-248. Specialty Drug Copayment Limitation Act of 2016.">April 7, 2017, D.C. Law 21-248, § 3a</a>; <a href="/us/dc/council/laws/23-252#§2(d)" title="">as added Mar. 16, 2021, D.C. Law 23-252, § 2(d), 68 DCR 001151</a>; <a href="/us/dc/council/laws/24-170#§5" title="§ 5.">Sept. 21, 2022, D.C. Law 24-170, § 5, 69 DCR 009207</a>.)
    </p>
                </aside>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/dc/council/code/sections/48-855.02b" data-order="|48|8H|48-855.02b|" data-ref-path="§48-855.02b" class="h__section">§ 48–855.02b. Calculation of member's contributions for a prescription drug covered under the health benefit plan.</h2>
                <p class="text-indent-1"><span class="level-num" id="/us/dc/council/code/sections/48-855.02b#(a)">(a)</span> Except as otherwise provided in subsection (b) of this section, when calculating a member's contribution to their coinsurance, copayment, cost-sharing responsibility, deductible, or out-of-pocket maximum under the member's health benefit plan, the health insurer shall  include any discount, financial assistance payment, product voucher, or any other out-of-pocket expense made by or on behalf of the member for a prescription drug covered under the member's health benefit plan that:</p>
                <p class="text-indent-2"><span class="level-num" id="/us/dc/council/code/sections/48-855.02b#(a)(1)">(1)</span> Is without a generic drug equivalent or an interchangeable biological product preferred under the health benefit plan's formulary; or</p>
                <p class="text-indent-2"><span class="level-num" id="/us/dc/council/code/sections/48-855.02b#(a)(2)">(2)</span> Has a generic equivalent drug or an interchangeable biological product preferred under the health benefit plan's formulary where the member has obtained access to the drug through prior authorization, a step therapy protocol, or the exception or appeal process of the health insurer or pharmacy benefits manager.</p>
                <p class="text-indent-1"><span class="level-num" id="/us/dc/council/code/sections/48-855.02b#(b)">(b)</span> Subsection (a) of this section shall not apply to a member covered by a high deductible health plan, as that term is defined under 26 U.S.C. § 223, until the member satisfies their minimum deductible; except, that subsection (a) of this section shall apply to contribution amounts made for preventative care, as that term is defined under 26 U.S.C. § 223(c)(2)(C).</p>
                <p class="text-indent-1"><span class="level-num" id="/us/dc/council/code/sections/48-855.02b#(c)">(c)</span> This section shall apply to health benefit plans entered into, amended, extended, or renewed on or after January 1, 2025.</p>
                <aside class="annotations" role="note">
                  <p>
      (<a href="/us/dc/council/laws/21-248" title="D.C. Law 21-248. Specialty Drug Copayment Limitation Act of 2016.">Apr. 17, 2017, D.C. Law 21-248, § 3b</a>; <a href="/us/dc/council/laws/25-26#§2(b)" title="">as added July 20, 2023, D.C. Law 25-26, § 2(b), 70 DCR 7912</a>.)
    </p>
                </aside>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/dc/council/code/sections/48-855.03" data-order="|48|8H|48-855.03|" data-ref-path="§48-855.03" class="h__section">§ 48–855.03. Applicability.</h2>
                <p><a class="internal-link no-wrap" href="/us/dc/council/code/titles/48/chapters/8H" title="Chapter 8H. Specialty Drug Copayment Limitation.">This chapter</a> shall apply to a health benefit plan effective, or renewed, on or after January 1, 2018; except, that <a class="internal-link no-wrap" href="/us/dc/council/code/sections/48-855.02a" title="§ 48–855.02a. Insulin copayment or coinsurance limitation.">§ 48-855.02a</a> shall apply on January 1, 2022[].</p>
                <aside class="annotations" role="note">
                  <p>
      (<a href="/us/dc/council/laws/21-248#§4" title="§ 4. Applicability.">Apr. 7, 2017, D.C. Law 21-248, § 4, 64 DCR 1624</a>; <a href="/us/dc/council/laws/23-252#§2(c)" title="">Mar. 16, 2021, D.C. Law 23-252, § 2(c), 68 DCR 001151</a>.)
    </p>
                </aside>
                <hr class="section-separator" aria-hidden="true"/>
              </div>
            </article>
          </main>
          <nav id="area__navigation_mini" class="ns__document__us-dc" aria-label="Previous and next article links">
            <section>
              <a href="/us/dc/council/code/titles/48/chapters/8G" aria-label="Chapter 8G. Prescription Drug Monitoring.">
                <div class="h__ui">Previous</div>
                <span>Chapter 8G. Prescription Drug Monitoring.</span>
              </a>
            </section>
            <section>
              <a href="/us/dc/council/code/titles/48/chapters/9" aria-label="Chapter 9. Controlled Substances Act.">
                <div class="h__ui">Next</div>
                <span>Chapter 9. Controlled Substances Act.</span>
              </a>
            </section>
          </nav>
        </div>
      </div>
      <footer id="section__footer" class="ns__document__us-dc">
        <div id="section__footer__inner" class="ns__document__us-dc">
          <section id="area__footer__logo" class="ns__document__us-dc">
            <a href="/" class="logo" aria-label="Logo - Return to home page">
              <img src="/us/dc/_document/v2/images/logo/dc-seal.png" srcset="/us/dc/_document/v2/images/logo/dc-seal.png 1x, /us/dc/_document/v2/images/logo/dc-seal@2x.png 2x" alt="Council of the District of Columbia logo"/>
            </a>
          </section>
          <div id="area__footer__content" class="ns__document__us-dc">
            <p>The codes and laws on this website are in the public domain.</p>
            <p>
      Please do not scrape. Instead, bulk download the <a href="https://github.com/dccouncil/law-html">HTML</a> or <a href="https://github.com/dccouncil/law-xml">XML</a>.
    </p>
            <p>Powered by the non-profit <a href="http://www.openlawlib.org/">Open Law Library</a>.</p>
          </div>
        </div>
      </footer>
    </div>
    <!--Piwik analytics-->
    <noscript>
      <img src="/_analytics/pixel.png" style="border:0;" alt=""/>
    </noscript>
  </body>
</html>
